ketoconazole and cp 154526

ketoconazole has been researched along with cp 154526 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clampitt, DM; Goeders, NE1
Goeders, NE; Moffett, MC1

Other Studies

2 other study(ies) available for ketoconazole and cp 154526

ArticleYear
Potential role for the hypothalamo-pituitary-adrenal axis in the conditioned reinforcer-induced reinstatement of extinguished cocaine seeking in rats.
    Psychopharmacology, 2002, Volume: 161, Issue:3

    Topics: Analysis of Variance; Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Corticosterone; Extinction, Psychological; Hypothalamo-Hypophyseal System; Ketoconazole; Male; Pituitary-Adrenal System; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Reinforcement Schedule; Reinforcement, Psychology; Self Administration; Stress, Psychological

2002
CP-154,526, a CRF type-1 receptor antagonist, attenuates the cue-and methamphetamine-induced reinstatement of extinguished methamphetamine-seeking behavior in rats.
    Psychopharmacology, 2007, Volume: 190, Issue:2

    Topics: Amphetamine-Related Disorders; Animals; Corticotropin-Releasing Hormone; Cues; Dose-Response Relationship, Drug; Extinction, Psychological; Hypothalamo-Hypophyseal System; Infusions, Intravenous; Injections, Intraperitoneal; Injections, Intraventricular; Ketoconazole; Male; Methamphetamine; Motivation; Pituitary-Adrenal System; Premedication; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Self Administration

2007